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Urethral Alarm Probe for Permanent Prostate Implants 
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We have developed a urethral dosimetry system for real time dose verification along the urethra during 
permanent implant prostate brachytherapy. The urethral alarm probe uses “spectroscopic dosimetry” to calculate the 
dose rate along the urethra in real time. The application of spectroscopic dosimetry for the urethral alarm probe was 
verified using Monte Carlo calculations. In phantom depth dose measurements as well as isotropy measurements 
were performed to verify the usefulness of the urethra alarm probe as an in vivo real time dosimeter. 
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I. Introduction   
Permanent prostate implants are a common treatment 
modality for early stage prostate cancer. Reducing the risk of 
complications, whilst at the same time maintaining good 
dosimetric coverage of the tumor, is a major concern in 
prostate brachytherapy. We have developed a probe which 
measures in real time the dose delivered along the urethra 
and may be used by the physicians during seed implantation 
to monitor for excessive doses. In vivo dosimetry is 
commonly performed with miniature radiation detectors 
such as MOSFETs or diodes1). The main disadvantages of 
such systems are energy dependence and low sensitivity. The 
urethral alarm probe circumvents these problems by 
measuring the energy spectrum of the treatment radiation 
field. The dose rate at the point of measurement is 
proportional to the magnitude of the measured photopeaks. 
The urethral alarm probe consists of a silicon mini-detector 
connected to a shaping amplifier and discriminator, located 
inside a cable small enough to be inserted within a urethral 
catheter. A portable data acquisition system provides real 
time dose calculations and extrapolated total treatment doses. 
The following reports on Monte Carlo calculations and 
physical experiments to confirm the suitability of 
spectroscopic dosimetry as a tool for low dose rate in vivo 
measurements. 
 
II. Methodology 
1. Monte Carlo Simulations 
EGSnrc v42) was used for the following Monte Carlo 
simulations. The user code DOSRZnrc was used to score 
doses in a water phantom whereas the user code FLURZnrc 
was used to score particle fluence in a water phantom.  
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An iodine 125 based brachytherapy seed, model 6711 
from Amersham Health, was modeled in a large liquid water 
phantom. The dose deposited in the phantom was recorded at 
5 mm intervals up to 5cm from the seed along the transverse 
axis and normalized to 1 at 1cm. The particle fluence was 
also recorded at 5mm intervals up to 5cm from the seed long 
the transverse axis. The number of events in the photopeaks 
were counted for each of the spectra and normalized to 1 at 
1cm, to simulate the application of spectroscopic dosimetry, 
calibrated at a distance of 1cm from the seed. The two depth-
dose curves were plotted to compare the DOSRZnrc 
predicted dose and the spectroscopic dosimetry predicted 
dose. 
 
2. Phantom Measurements 
1) Depth dose measurements 
An iodine 125 based seed was placed inside a gel 
phantom. The urethral alarm probe was used to measure the 
extrapolated treatment dose at various distances from the 
seed along the transverse axis. These doses were plotted in 
comparison with TG43 (3) calculated doses. 
 
2) Isotropy measurements 
An iodine 125 based seed was placed inside a gel 
phantom. The urethral probe was placed 1cm from the seed 
on the transverse axis of the seed. The probe was rotated 360° 
with measurement taken every 30° to measure the azimuth 
isotropy of the detector. The probe was then moved parallel 
to the seed with measurements taken every 5mm. Each step 
of 5mm increased the polar angle of measurement, but also 
increased the source to detector distance. The measured dose 
vs. expected dose was plotted to investigate the polar 
isotropy of the detector. 
 
III Results 
1. Monte Carlo Simulations 
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The application of spectroscopic dosimetry has been 
simulated using FLURZnrc. Fig. 1 shows the comparison of 
spectra measured at 0.5cm and 5cm from an iodine 125 
based seed. It can be seen from Fig. 1 that the shape of the 
spectrum does not change significantly with distance, 
although the fluence has greatly decreased. This indicates 
that spectroscopic dosimetry may be viable over a large 
range of depths (up to 5cm from sources). 
a) 
 
b) 
 
Fig.1 Spectra at depths of a) 0.5cm and b) 5cm from an iodine 125 
seed.  
 
Fig. 2 Spectroscopic dosimetry predicted dose and DOSRZnrc 
predicted dose vs. depth 
 
Fig. 2 shows the depth dose curves for both the 
spectroscopic dosimetry predicted doses and calculated 
doses, up to 5cm from an iodine 125 based seed. 
Spectroscopic dosimetry has predicted the dose to within 2% 
of the calculated dose for each point of measurement. 
 
2. Phantom Measurements 
The measured spectrum of an iodine 125 based seed in 
free air is shown in Fig. 3. Several peaks are well resolved, 
indicating the urethral alarm probe is adequate for 
performing spectroscopy based dose calculations. 
 
Fig. 3 Iodine 125 based seed spectrum as measured by the urethral 
alarm probe at a distance of 1cm in free air. 
 
Depth dose curves for an iodine 125 based seed in a gel 
phantom as measured by the urethral alarm probe and as 
calculated by TG43 are shown in Fig. 4. The urethral alarm 
probe has measured the doses to within 5% of the expected 
doses. 
 
Fig. 4 Depth dose curve from an Iodine 125 based seed in a gel 
phantom as measured by the urethral alarm probe and calculated 
using TG433). 
 
The azimuthal isotropy of the urethral alarm probe is 
represented in Fig. 5. The urethral alarm probe has an 
isotropy within 4% of the mean response for 360° about the 
detector azimuth. 
 
 
Fig. 5 Azimuthal isotropy of the urethral alarm probe 
 
The polar isotropy of the urethra alarm probe is 
represented in Fig. 6. The decrease in dose with an increase 
of angle between transverse axis of the seed and direction 
from the seed center to the detector is due to the increasing 
source to detector distance. The measured doses were within 
5% of the calculated doses. The urethral alarm probe exhibits 
a polar isotropy to within 5% for angles up to 80° from the 
polar axis. 
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Fig. 6 Polar isotropy of the urethral alarm probe 
 
IV. Conclusion 
 The urethral alarm probe has been developed to provide 
real time dosimetry for permanent implant prostate 
brachytherapy. Monte Carlo calculations have shown 
spectroscopic dosimetry to be accurate to within 2% up to 
5cm from low energy x-ray sources with distinct emission 
spectra. The urethra alarm probe uses spectroscopic 
dosimetry to measure low dose rates to an accuracy of within 
5% of calculated doses, up to 5cm from sources, and for all 
angles of incidence about the detector (for both azimuth and 
polar angles). 
The urethral alarm probe demonstrates the ability for real 
time in vivo dose measurements using spectroscopic 
dosimetry. The patented urethral alarm probe will be a very 
useful tool in clinical dose verification both during seed 
implantation and post implant. 
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